KINNATE BIOPHARMA INC - COM (KNTE)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM
Number of holders
61
Total Shares
38.4M
Shares change
-314K
Total reported value, excl. options
$91M
Value change
+$3.74M
Put/Call ratio
193.09
Number of buys
34
Number of sells
-25
Price
$2.37
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.